Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
Not Confirmed
Not Confirmed
29 September-01 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Industry Trade Show
Not Confirmed
29 September-01 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
25 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/25/3156222/0/en/Nuvectis-Pharma-Appoints-Biotech-Executive-Juan-Sanchez-MD-to-the-Board-of-Directors.html
04 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/04/3144379/0/en/Nuvectis-Pharma-to-Participate-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html
11 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/11/3131309/0/en/Nuvectis-Pharma-Announces-the-Initiation-of-the-Phase-1b-Program-for-NXP900.html
05 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/05/3127240/0/en/Nuvectis-Pharma-Inc-Reports-Second-Quarter-2025-Financial-Results-and-Business-Highlights.html
31 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/31/3124897/0/en/Nuvectis-Pharma-Provides-Final-Clinical-Data-Update-from-the-NXP800-Phase-1b-Study-in-Ovarian-Cancer-and-Reports-Completion-of-the-NXP900-Phase-1a-Dose-Escalation-Study.html
31 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/nuvectis-axes-ovarian-cancer-program-after-seeing-phase-1b-data
ABOUT THIS PAGE